Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print RSS Feed

Breaking News

Related Searches: Industry News •
West Opens Injection Molding Plant in China

September 29, 2009
West Pharmaceutical Services, Inc. has opened its new 129,000-sq.-ft. injection-molding factory in the Shanghai Qingpu Industrial Zone (SQIZ) in China.  Read More »
Vetter Inaugurates Ravensburg South Site

September 29, 2009
Vetter recently inaugurated its Ravensburg South site with a new 862,000 sq.-ft. area that now includes facilities for the aseptic filling and packaging of injectable drugs.  Read More »
Abbott to Acquire Solvay’s Pharma Business

September 28, 2009
Abbott has entered a definitive agreement with the Solvay Group to acquire Solvay's pharmaceuticals business for $6.6 billion in cash.  Read More »
J&J Buys Stake in Crucell, Enters Vaccine Pact

September 28, 2009
Johnson & Johnson, through its subsidiary Ortho-McNeil-Janssen Pharmaceuticals, Inc., and Crucell have entered into a strategic collaboration for the discovery, development and commercialization of monoclonal antibodies and vaccines for the treatment and   Read More »
Opexa Hits Transfer Milestone with Novartis

September 23, 2009
Opexa achieved its first milestone in its stem cell pact with Novartis.  Read More »
ImmuneRegen, Azopharma in Homspera Pact

September 23, 2009
Azopharma will perform research services to further develop ImmuneRegen's lead drug candidate Homspera  Read More »
Pfizer, Wyeth to Divest Animal Health Assets

September 22, 2009
Pfizer and Wyeth have entered into an agreement with Boehringer Ingelheim to divest certain animal health assets, pending Pfizer’s acquisition of Wyeth.   Read More »
Avid, Boehringer Ingelheim Enter Production Pact

September 22, 2009
Avid Bioservices, Inc. and Boehringer Ingelheim have entered into a global strategic production alliance agreement, under which Avid will become an approved member of BI's global Production Alliance Network (PAN) Biologics.  Read More »
Toxikon Expands Immunotoxicology Services

September 22, 2009
Toxikon Corp. has expanded its immunotoxicology offerings, adding flow cyctometry, which enables the direct analysis of cells to detect a variety of specifically labeled components.  Read More »
Icagen, Pfizer Extend Pain Pact

September 21, 2009
Icagen, Inc. and Pfizer have extended their worldwide collaboration and licensing agreement aimed at discovering, developing and commercializing compounds as new potential treatments for pain and related disorders.  Read More »
DOR BioPharma Gets $9.4 Million NIH Grant

September 21, 2009
DOR BioPharma has been awarded a $9.4 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH).  Read More »
Anavex Completes Scale-up for AD Drug

September 21, 2009
Anavex Life Sciences Corp. has completed the scale-up manufacturing of Anavex 2-73, its lead compound for the treatment of Alzheimer's disease.  Read More »
Wyeth, Ambrx Form Multi-target Alliance

September 18, 2009
Wyeth and Ambrx, Inc. have formed a worldwide alliance to discover, develop, and commercialize protein drug candidates for three undisclosed targets.  Read More »
Novartis Gains Approval for Valturna Combo

September 18, 2009
The FDA has approved Novartis’ Valturna (aliskiren and valsartan) tablets, a medicine targeting two key points within the renin system, also known as the renin angiotensin aldosterone system (RAAS), a regulator of blood pressure.  Read More »
CambReg, SIRO Clinpharm Form Alliance

September 18, 2009
Cambridge Regulatory Services (CambReg) has formed a strategic alliance with SIRO Clinpharm, a global Indian-based CRO, to provide services to pharma companies in both Asia and Europe.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: